Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer.
Nandi A, Debnath R, Nayak A, To TKJ, Thacker G, Reilly M, Gumber S, Karagounis I, Li N, Lengner CJ, Haldar M, Welm AL, Blanco AM, Thomas C, Chakrabarti R. Nandi A, et al. Among authors: nayak a. Cancer Res. 2022 Oct 17;82(20):3718-3733. doi: 10.1158/0008-5472.CAN-21-1225. Cancer Res. 2022. PMID: 36007109 Free PMC article.
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
Kumar S, Srivastav RK, Wilkes DW, Ross T, Kim S, Kowalski J, Chatla S, Zhang Q, Nayak A, Guha M, Fuchs SY, Thomas C, Chakrabarti R. Kumar S, et al. Among authors: nayak a. Oncogene. 2019 Mar;38(12):2092-2107. doi: 10.1038/s41388-018-0562-z. Epub 2018 Nov 15. Oncogene. 2019. PMID: 30442981 Free PMC article.
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.
Kraya AA, Maxwell KN, Wubbenhorst B, Wenz BM, Pluta J, Rech AJ, Dorfman LM, Lunceford N, Barrett A, Mitra N, Morrissette JJD, Feldman M, Nayak A, Domchek SM, Vonderheide RH, Nathanson KL. Kraya AA, et al. Among authors: nayak a. Clin Cancer Res. 2019 Jul 15;25(14):4363-4374. doi: 10.1158/1078-0432.CCR-18-0468. Epub 2019 Mar 26. Clin Cancer Res. 2019. PMID: 30914433 Free PMC article.
Immature natural killer cells promote progression of triple-negative breast cancer.
Thacker G, Henry S, Nandi A, Debnath R, Singh S, Nayak A, Susnik B, Boone MM, Zhang Q, Kesmodel SB, Gumber S, Das GM, Kambayashi T, Dos Santos CO, Chakrabarti R. Thacker G, et al. Among authors: nayak a. Sci Transl Med. 2023 Mar 8;15(686):eabl4414. doi: 10.1126/scitranslmed.abl4414. Epub 2023 Mar 8. Sci Transl Med. 2023. PMID: 36888695 Free PMC article.
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women.
Gallagher EJ, Fei K, Feldman SM, Port E, Friedman NB, Boolbol SK, Killelea B, Pilewskie M, Choi L, King T, Nayak A, Franco R, Cruz D, Antoniou IM, LeRoith D, Bickell NA. Gallagher EJ, et al. Among authors: nayak a. Breast Cancer Res. 2020 May 12;22(1):40. doi: 10.1186/s13058-020-01281-y. Breast Cancer Res. 2020. PMID: 32393319 Free PMC article.
A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers.
Hamalian S, Güth R, Runa F, Sanchez F, Vickers E, Agajanian M, Molnar J, Nguyen T, Gamez J, Humphries JD, Nayak A, Humphries MJ, Tchou J, Zervantonakis IK, Kelber JA. Hamalian S, et al. Among authors: nayak a. Oncogene. 2021 Aug;40(33):5224-5235. doi: 10.1038/s41388-021-01906-2. Epub 2021 Jul 8. Oncogene. 2021. PMID: 34239043 Free PMC article.
PTGES3 is a Putative Prognostic Marker in Breast Cancer.
Adekeye A, Agarwal D, Nayak A, Tchou J. Adekeye A, et al. Among authors: nayak a. J Surg Res. 2022 Mar;271:154-162. doi: 10.1016/j.jss.2021.08.033. Epub 2021 Dec 15. J Surg Res. 2022. PMID: 34920330
1,486 results